146 related articles for article (PubMed ID: 20861193)
1. Diagnosis of cardiac disease in pediatric end-stage renal disease.
Chavers BM; Solid CA; Sinaiko A; Daniels FX; Chen SC; Collins AJ; Frankenfield DL; Herzog CA
Nephrol Dial Transplant; 2011 May; 26(5):1640-5. PubMed ID: 20861193
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and prevalence of cardiac diseases in Egyptian pediatric patients with end-stage renal disease on regular hemodialysis.
El-Gamasy MA; Mawlana WH
Saudi J Kidney Dis Transpl; 2019; 30(1):53-61. PubMed ID: 30804267
[TBL] [Abstract][Full Text] [Related]
3. Hypertension in pediatric long-term hemodialysis patients in the United States.
Chavers BM; Solid CA; Daniels FX; Chen SC; Collins AJ; Frankenfield DL; Herzog CA
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1363-9. PubMed ID: 19556378
[TBL] [Abstract][Full Text] [Related]
4. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
5. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients.
Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G
Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591
[TBL] [Abstract][Full Text] [Related]
7. When does the cardiovascular disease appear in patients with chronic kidney disease?
Sozeri B; Mir S; Kara OD; Levent E
Pediatr Cardiol; 2010 Aug; 31(6):821-8. PubMed ID: 20401476
[TBL] [Abstract][Full Text] [Related]
8. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
Rheault MN; Molony JT; Nevins T; Herzog CA; Chavers BM
Kidney Int; 2017 Jan; 91(1):177-182. PubMed ID: 27865440
[TBL] [Abstract][Full Text] [Related]
10. Changes of cardiac functions after hemodialysis session in pediatric patients with end-stage renal disease: conventional echocardiography and two-dimensional speckle tracking study.
Rakha S; Hafez M; Bakr A; Hamdy N
Pediatr Nephrol; 2020 May; 35(5):861-870. PubMed ID: 31925535
[TBL] [Abstract][Full Text] [Related]
11. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
[TBL] [Abstract][Full Text] [Related]
12. Impact of specialization of primary nephrologist on the care of pediatric hemodialysis patients.
Fadrowski JJ; Frankenfield DL; Friedman AL; Warady BA; Neu AM; Fivush BA
Am J Kidney Dis; 2006 Jan; 47(1):115-21. PubMed ID: 16377392
[TBL] [Abstract][Full Text] [Related]
13. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
Block GA; Hulbert-Shearon TE; Levin NW; Port FK
Am J Kidney Dis; 1998 Apr; 31(4):607-17. PubMed ID: 9531176
[TBL] [Abstract][Full Text] [Related]
14. Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project.
Fadrowski JJ; Frankenfield D; Amaral S; Brady T; Gorman GH; Warady B; Furth SL; Fivush B; Neu AM
Am J Kidney Dis; 2007 Dec; 50(6):958-66. PubMed ID: 18037097
[TBL] [Abstract][Full Text] [Related]
15. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?
Raggi P; Boulay A; Chasan-Taber S; Amin N; Dillon M; Burke SK; Chertow GM
J Am Coll Cardiol; 2002 Feb; 39(4):695-701. PubMed ID: 11849871
[TBL] [Abstract][Full Text] [Related]
16. Does greater pediatric experience influence treatment choices in chronic disease management? Dialysis modality choice for children with end-stage renal disease.
Furth SL; Powe NR; Hwang W; Neu AM; Fivush BA
Arch Pediatr Adolesc Med; 1997 Jun; 151(6):545-50. PubMed ID: 9193235
[TBL] [Abstract][Full Text] [Related]
17. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
[TBL] [Abstract][Full Text] [Related]
18. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular complications in pediatric end-stage renal disease.
Parekh RS; Gidding SS
Pediatr Nephrol; 2005 Feb; 20(2):125-31. PubMed ID: 15599775
[TBL] [Abstract][Full Text] [Related]
20. Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.
Kuwahara M; Takehara E; Sasaki Y; Azetsu H; Kusaka K; Shikuma S; Akita W
Ther Apher Dial; 2016 Feb; 20(1):12-9. PubMed ID: 26679409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
